Literature DB >> 21719283

Benzisothiazolones as modulators of macrophage migration inhibitory factor.

William L Jorgensen1, Alexander Trofimov, Xin Du, Alissa A Hare, Lin Leng, Richard Bucala.   

Abstract

Substituted N-phenylbenzisothiazolones have been investigated as inhibitors on class="Chemical">f the tautomerase activity of the proinflammatory cytokine MIF (macrophage migration inhibitory factor). Numerous compounds were found to possess antagonist activity in the low micromolar range with the most potent being the 6-hydroxy analog 1w. Compound 1w and the p-cyano analog 1c were also shown to exhibit significant inhibition of the binding of MIF to its transmembrane receptor CD74. Consistently, both compounds were also found to retard the MIF-dependent phosphorylation of ERK1/2 in human synovial fibroblasts.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21719283      PMCID: PMC3139435          DOI: 10.1016/j.bmcl.2011.05.127

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  37 in total

Review 1.  Molecular modeling of organic and biomolecular systems using BOSS and MCPRO.

Authors:  William L Jorgensen; Julian Tirado-Rives
Journal:  J Comput Chem       Date:  2005-12       Impact factor: 3.376

Review 2.  Macrophage migration inhibitory factor: a critical component of autoimmune inflammatory diseases.

Authors:  Richard Bucala; Elias Lolis
Journal:  Drug News Perspect       Date:  2005-09

3.  Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response.

Authors:  Robert A Mitchell; Hong Liao; Jason Chesney; Gunter Fingerle-Rowson; John Baugh; John David; Richard Bucala
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-26       Impact factor: 11.205

Review 4.  Autoimmune diseases: MIF as a therapeutic target.

Authors:  Dorothee Greven; Lin Leng; Richard Bucala
Journal:  Expert Opin Ther Targets       Date:  2010-03       Impact factor: 6.902

5.  Fragment screening of inhibitors for MIF tautomerase reveals a cryptic surface binding site.

Authors:  Larry R McLean; Ying Zhang; Hua Li; Yong-Mi Choi; Zuoning Han; Roy J Vaz; Yi Li
Journal:  Bioorg Med Chem Lett       Date:  2010-02-06       Impact factor: 2.823

6.  Macrophage migration inhibitory factor is a therapeutic target in treatment of non-insulin-dependent diabetes mellitus.

Authors:  Yuriko Sanchez-Zamora; Luis I Terrazas; Alonso Vilches-Flores; Emmanuel Leal; Imelda Juárez; Caroline Whitacre; Aaron Kithcart; James Pruitt; Thais Sielecki; Abhay R Satoskar; Miriam Rodriguez-Sosa
Journal:  FASEB J       Date:  2010-03-04       Impact factor: 5.191

Review 7.  Role of macrophage migration inhibition factor in kidney disease.

Authors:  Hui Y Lan
Journal:  Nephron Exp Nephrol       Date:  2008-07-25

8.  Discovery of human macrophage migration inhibitory factor (MIF)-CD74 antagonists via virtual screening.

Authors:  Zoe Cournia; Lin Leng; Sunilkumar Gandavadi; Xin Du; Richard Bucala; William L Jorgensen
Journal:  J Med Chem       Date:  2009-01-22       Impact factor: 7.446

Review 9.  Macrophage migration inhibitory factor: a noncanonical chemokine important in atherosclerosis.

Authors:  Heidi Noels; Jürgen Bernhagen; Christian Weber
Journal:  Trends Cardiovasc Med       Date:  2009-04       Impact factor: 6.677

10.  MIF as a glucocorticoid-induced modulator of cytokine production.

Authors:  T Calandra; J Bernhagen; C N Metz; L A Spiegel; M Bacher; T Donnelly; A Cerami; R Bucala
Journal:  Nature       Date:  1995-09-07       Impact factor: 49.962

View more
  8 in total

1.  Advances and Insights for Small Molecule Inhibition of Macrophage Migration Inhibitory Factor.

Authors:  Vinay Trivedi-Parmar; William L Jorgensen
Journal:  J Med Chem       Date:  2018-06-04       Impact factor: 7.446

Review 2.  Macrophage migration inhibitory factor (MIF) as a therapeutic target for rheumatoid arthritis and systemic lupus erythematosus.

Authors:  Joshua B Bilsborrow; Edward Doherty; Pathricia V Tilstam; Richard Bucala
Journal:  Expert Opin Ther Targets       Date:  2019-08-20       Impact factor: 6.902

3.  Homotrimeric macrophage migration inhibitory factor (MIF) drives inflammatory responses in the corneal epithelium by promoting caveolin-rich platform assembly in response to infection.

Authors:  Thomas Reidy; Alexander Rittenberg; Markryan Dwyer; Samantha D'Ortona; Gerald Pier; Mihaela Gadjeva
Journal:  J Biol Chem       Date:  2013-01-31       Impact factor: 5.157

4.  Design, synthesis and characterization of novel 1,2-benzisothiazol-3(2H)-one and 1,3,4-oxadiazole hybrid derivatives: potent inhibitors of Dengue and West Nile virus NS2B/NS3 proteases.

Authors:  Huiguo Lai; Dengfeng Dou; Sridhar Aravapalli; Tadahisa Teramoto; Gerald H Lushington; Tom M Mwania; Kevin R Alliston; David M Eichhorn; Radhakrishnan Padmanabhan; William C Groutas
Journal:  Bioorg Med Chem       Date:  2012-11-15       Impact factor: 3.641

5.  An Analysis of MIF Structural Features that Control Functional Activation of CD74.

Authors:  Georgios Pantouris; Mansoor Ali Syed; Chengpeng Fan; Deepa Rajasekaran; Thomas Yoonsang Cho; Eric M Rosenberg; Richard Bucala; Vineet Bhandari; Elias J Lolis
Journal:  Chem Biol       Date:  2015-09-10

6.  Identification of small molecule inhibitors of Jumonji AT-rich interactive domain 1B (JARID1B) histone demethylase by a sensitive high throughput screen.

Authors:  Joyce Sayegh; Jian Cao; Mike Ran Zou; Alfonso Morales; Lauren P Blair; Michael Norcia; Denton Hoyer; Alan J Tackett; Jane S Merkel; Qin Yan
Journal:  J Biol Chem       Date:  2013-02-13       Impact factor: 5.157

7.  Targeting distinct tautomerase sites of D-DT and MIF with a single molecule for inhibition of neutrophil lung recruitment.

Authors:  Deepa Rajasekaran; Swen Zierow; Mansoor Syed; Richard Bucala; Vineet Bhandari; Elias J Lolis
Journal:  FASEB J       Date:  2014-07-11       Impact factor: 5.191

8.  Crystallographic and receptor binding characterization of Plasmodium falciparum macrophage migration inhibitory factor complexed to two potent inhibitors.

Authors:  Georgios Pantouris; Deepa Rajasekaran; Alvaro Baeza Garcia; Victor G Ruiz; Lin Leng; William L Jorgensen; Richard Bucala; Elias J Lolis
Journal:  J Med Chem       Date:  2014-10-08       Impact factor: 7.446

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.